U.S. Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Drug Manufacturers
Biofrontera Inc (BFRI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing Growth Opportunities
Despite a dip in revenue and a net loss increase, Biofrontera Inc outlines strategic adjustments and promising developments in its latest earnings call. 57 minutes ago
GuruFocus Research Drug Manufacturers
Medicine Man Technologies Inc (SHWZ) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Opportunities
Despite facing increased operational costs and competitive pressures, SHWZ reports revenue growth and strategic adjustments in Q1 2024. 1 day ago
GuruFocus Research Drug Manufacturers
TILT Holdings Inc (TLLTF) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing Opportunities
Explore the strategic adjustments and operational insights from TILT Holdings Inc's first quarter of 2024, amidst financial fluctuations and market dynamics. 1 day ago
GuruFocus Research Drug Manufacturers
cbdMD Inc (YCBD) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges with Strategic Adjustments and Cost-Cutting Initiatives
Despite a downturn in sales, cbdMD Inc focuses on operational efficiency and market expansion to steer towards profitability. 1 day ago
GuruFocus Research Drug Manufacturers
Cresco Labs Inc (CRLBF) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth Amidst Market Challenges
Discover how Cresco Labs Inc (CRLBF) is navigating financial growth, operational efficiencies, and market expansions in a challenging environment. 1 day ago
GuruFocus Research Drug Manufacturers
Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: Navigating Challenges, Maintaining Resilience
Despite flat year-over-year revenue and supply chain hurdles, PBH achieves significant deleveraging and projects optimistic fiscal '25 outlook. 1 day ago
GuruFocus Research Drug Manufacturers
Glass House Brands Inc (GLASF) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Expectations with Strategic Growth
Despite mixed financials, Glass House Brands Inc (GLASF) reports a robust start to 2024, exceeding revenue and production forecasts while navigating market challenges. 1 day ago